Related to Patient Privacy or Scientific Advances: Do They Have to Be Mutually Exclusive?

• Life Technologies and Cancer Centers Form Whole-Genome Sequencing Alliance
  
• Illumina Cuts Price for Individual Genome Sequencing Service by More than Half
  
• Broad Institute to Replace Illumina’s Genome Analyzer IIx Systems with HiSeq 2000 Units
  
• Veracyte Raises $28M toward Launch of Thyroid Cancer Diagnostic
  
• Gladstone and Institute for Systems Biology to Conduct Whole-Genome Sequencing in Huntington Disease
  
• Qiagen Expands Partnership with Genome Diagnostics for Development of Six New HLA Tests
  
• NIH and Wellcome Trust Pledge $38M for Population-Based Genetic Studies in Africa
  
• SeqWright to Offer RainDance's Microdroplet-Based Sequence-Enrichment Platform
  
• Roche and IBM Set Sights on $100–1,000 Genome Nanopore Sequencing Platform
  
• SAIC-Frederick and Fluidigm to Decode Genome of Epstein-Barr Virus
  
• Cytos and Life Technologies Partner with A*Star in Separate Deals
  
• TriLink to Provide Affymetrix with Oligonucleotides
  
• Illumina Gives Researchers Access to Large-Scale Whole Human Genome Sequencing
  
• Baylor Genome Center to Sequence 5,000 Exomes Using Roche NimbleGen Capture Technology
  
• Life Technologies and UCSD Enter CLL Sequencing Research Program
  
• NIH Bankrolls Six Centers with $100M to Characterize Human Immune Responses
  
• Life Tech Snaps Up Ion Torrent in $375–$725M Deal for Semiconductor Sequencing Platform
  
• SeqWright Adds Illumina’s HiSeq 2000 to Its Sequencing Offerings
  
• FDA Selects Ariana’s KEM Platform for Biomarker Signature Validation
  
• UCSF Wins Two NIH Grants Worth $15.1M to Progress Pharmacogenomics Research